cyclohexanol has been researched along with Hepatic Encephalopathy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hjorth, S; Kullingsjö, J; Wikell, C | 1 |
| García-Ramos, G; Guevara, L; Méndez-Sánchez, N; Morán, S; Poo, JL; Uribe, M | 1 |
| Andersson, G; Apelqvist, G; Bengtsson, F; Bergqvist, PB; Hindfelt, B; Wikell, C | 1 |
| Ahlner, J; Apelqvist, G; Baumann, P; Bengtsson, F; Eap, CB; Josefsson, M; Wikell, C | 1 |
1 trial(s) available for cyclohexanol and Hepatic Encephalopathy
| Article | Year |
|---|---|
Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial.
Topics: Cyclohexanols; Disaccharidases; Disaccharides; Double-Blind Method; Enzyme Inhibitors; Female; Hepatic Encephalopathy; Humans; Intestinal Absorption; Male; Middle Aged | 1998 |
3 other study(ies) available for cyclohexanol and Hepatic Encephalopathy
| Article | Year |
|---|---|
Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Cyclohexanols; Dialysis Solutions; Disease Models, Animal; Enzyme Inhibitors; Hepatic Encephalopathy; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2002 |
Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Chronic Disease; Citalopram; Cyclohexanols; Hepatic Encephalopathy; Locomotion; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 1999 |
Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Disease Models, Animal; Hepatic Encephalopathy; Humans; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Safety; Stereoisomerism; Venlafaxine Hydrochloride | 2002 |